Base Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A2

  • Investors
  • 11

Base Therapeutics General Information

Description

Developer of cell and gene editing technology designed to treat cancerous diseases. The company offers proprietary base editing platforms, prime editing technologies, and engineered immune cell therapy programs, enabling biotechnology companies, pharmaceutical developers, and medical researchers to develop precise gene therapies and cell-based treatments with improved editing accuracy and therapeutic potential.

Contact Information

Website
www.basetherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, Building F, Number 23, 200 Jinsu Road & 700 Jiqiao Road
  • Pudong New Area
  • Shanghai, 201206
  • China
+86 021
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1st Floor, Building F, Number 23, 200 Jinsu Road & 700 Jiqiao Road
  • Pudong New Area
  • Shanghai, 201206
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Base Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A2) 12-Sep-2024 Completed Generating Revenue
2. Early Stage VC (Series A1) 16-Jan-2023 Completed Generating Revenue
1. Seed Round 26-Jul-2021 $15.4M $15.4M Completed Startup
To view Base Therapeutics’s complete valuation and funding history, request access »

Base Therapeutics Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Base Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025152584-A1 Gene editing composition and use thereof Pending 15-Jan-2024

Base Therapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alibaba Entrepreneurs Fund Corporate Venture Capital Minority
Gobi Partners Venture Capital Minority
Baidu Ventures Corporate Venture Capital Minority
Beijing Guangda Huitong Private Equity Fund Management Growth/Expansion Minority
Great Eagle Holdings Real Estate Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Base Therapeutics FAQs

  • When was Base Therapeutics founded?

    Base Therapeutics was founded in 2021.

  • Where is Base Therapeutics headquartered?

    Base Therapeutics is headquartered in Shanghai, China.

  • What industry is Base Therapeutics in?

    Base Therapeutics’s primary industry is Discovery Tools (Healthcare).

  • Is Base Therapeutics a private or public company?

    Base Therapeutics is a Private company.

  • What is Base Therapeutics’s current revenue?

    The current revenue for Base Therapeutics is .

  • How much funding has Base Therapeutics raised over time?

    Base Therapeutics has raised $15.4M.

  • Who are Base Therapeutics’s investors?

    Alibaba Entrepreneurs Fund, Gobi Partners, Baidu Ventures, Beijing Guangda Huitong Private Equity Fund Management, and Great Eagle Holdings are 5 of 11 investors who have invested in Base Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process